• Je něco špatně v tomto záznamu ?

Měl by být Gleasonův systém klasifikace karcinomu prostaty modifikován tak, aby zohledňoval terciární komponenty vysokého stupně? Systematický přehled a metaanalýza
[Should the Gleason grading system for prostate cancer be modified to account for high-grade tertiary components? A systematic review and meta-analysis]

Patricia Harnden, Mike D. Shelley, Bernadette Coles, John Staffurth, Malcolm D. Mason ; Jiří Štipl (přeložil)

. 2007 ; 6 (3) : 246-255.

Jazyk čeština Země Česko

Perzistentní odkaz   https://www.medvik.cz/link/bmc07512779

The Gleason system for grading prostate cancer assigns a score on the basis of the most prevalent and second most prevalent grade. Several studies have investigated the clinical significance of a tertiary grade in radical prostatectomy samples. A systematic search of the published work identified seven studies that reported the prognostic value of a tertiary Gleason grade. Three studies correlated the presence of a tertiary grade with pathological stage, and six with prostate-specific antigen recurrence or clinical progression. In the small number of studies available, the frequency of a tertiary grade was consistently higher in samples characterised with pathological variables of poor outcome, such as extra-prostatic extension and positive surgical margins, but not lymph-node metastases. In five studies the presence of a tertiary grade increased the risk of prostate-specific antigen recurrence after radical prostatectomy by a factor of 2.5. However, modification of the Gleason score to include a tertiary grade in Gleason 4+3 tumours might overestimate the risk of seminal-vesicle or lymph-node invasion. This systematic review has established the association of a tertiary grade with poorer outcome than that associated with no tertiary grade. A tertiary grade should, therefore, be included in the pathological reporting of prostate cancer and be considered in the interpretation and design of clinical trials. However, all studies assessed for this review were retrospective, potentially affected by selection bias, and based on radical prostatectomy samples or transurethral resections rather than biopsy samples. Therefore, more evidence is needed to warrant the adaptation of the Gleason system to account for the presence of a tertiary grade, especially when scoring prostatic biopsies and applying predictive algorithms.

Should the Gleason grading system for prostate cancer be modified to account for high-grade tertiary components? A systematic review and meta-analysis

Bibliografie atd.

Lit.: 52

000      
00000naa 2200000 a 4500
001      
bmc07512779
003      
CZ-PrNML
005      
20180611073203.0
008      
081121s2007 xr e cze||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a cze $b eng
044    __
$a xr
100    1_
$a Harnden, Patricia
245    10
$a Měl by být Gleasonův systém klasifikace karcinomu prostaty modifikován tak, aby zohledňoval terciární komponenty vysokého stupně? Systematický přehled a metaanalýza / $c Patricia Harnden, Mike D. Shelley, Bernadette Coles, John Staffurth, Malcolm D. Mason ; Jiří Štipl (přeložil)
246    11
$a Should the Gleason grading system for prostate cancer be modified to account for high-grade tertiary components? A systematic review and meta-analysis
314    __
$a Cancer Research UK Clinical Centre, St James's University Hospital, Leeds
504    __
$a Lit.: 52
520    9_
$a The Gleason system for grading prostate cancer assigns a score on the basis of the most prevalent and second most prevalent grade. Several studies have investigated the clinical significance of a tertiary grade in radical prostatectomy samples. A systematic search of the published work identified seven studies that reported the prognostic value of a tertiary Gleason grade. Three studies correlated the presence of a tertiary grade with pathological stage, and six with prostate-specific antigen recurrence or clinical progression. In the small number of studies available, the frequency of a tertiary grade was consistently higher in samples characterised with pathological variables of poor outcome, such as extra-prostatic extension and positive surgical margins, but not lymph-node metastases. In five studies the presence of a tertiary grade increased the risk of prostate-specific antigen recurrence after radical prostatectomy by a factor of 2.5. However, modification of the Gleason score to include a tertiary grade in Gleason 4+3 tumours might overestimate the risk of seminal-vesicle or lymph-node invasion. This systematic review has established the association of a tertiary grade with poorer outcome than that associated with no tertiary grade. A tertiary grade should, therefore, be included in the pathological reporting of prostate cancer and be considered in the interpretation and design of clinical trials. However, all studies assessed for this review were retrospective, potentially affected by selection bias, and based on radical prostatectomy samples or transurethral resections rather than biopsy samples. Therefore, more evidence is needed to warrant the adaptation of the Gleason system to account for the presence of a tertiary grade, especially when scoring prostatic biopsies and applying predictive algorithms.
650    _2
$a buněčné jádro $x patologie $7 D002467
650    _2
$a progrese nemoci $7 D018450
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lokální recidiva nádoru $x prevence a kontrola $7 D009364
650    _2
$a prognóza $7 D011379
650    _2
$a prostatický specifický antigen $x krev $7 D017430
650    _2
$a prostatektomie $7 D011468
650    _2
$a nádory prostaty $x chirurgie $x krev $x patologie $7 D011471
700    1_
$a Shelley, Mike D.
700    1_
$a Coles, Bernadette
700    1_
$a Staffurth, John
700    1_
$a Mason, Malcolm $7 xx0225139
700    1_
$a Štipl, Jiří. $7 xx0244386
773    0_
$w MED00012637 $t The lancet oncology CZ $g Roč. 6, č. 3 (2007), s. 246-255 $x 1213-9432
787    18
$w bmc07512780 $i Recenze v: $t Komentář [k článku Měl by být Gleasonův systém klasifikace karcinomu prostaty modifikován tak, aby zohledňoval terciární komponenty vysokého stupně? Systematický přehled a metaanalýza]
910    __
$a ABA008 $b B 2277 $c 1153 b $y 1 $z 0
990    __
$a 20081118143934 $b ABA008
991    __
$a 20180611073413 $b ABA008
999    __
$a ok $b bmc $g 628373 $s 480820
BAS    __
$a 3
BMC    __
$a 2007 $b 6 $c 3 $d 246-255 $i 1213-9432 $m The lancet oncology CZ $x MED00012637
LZP    __
$a 2008-20/mkme

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...